Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04303702 · ClinicalTrials.gov registry record · NA

The Role of Oxytocin in the Second Stage of Labor

A NA study of Labor Complication, sponsored by Washington University School of Medicine.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT04303702 is a NA study of Labor Complication that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 400 participants, above the 237-participant average among 5 other Labor Complication trials with a reported enrollment target (69% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04303702, a NA study of Labor Complication, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

This is a randomized controlled trial investigating the utility of oxytocin administration in the second stage of labor.

Conditions Studied

Interventions

  • DRUG Continue Oxytocin
  • OTHER Discontinue Oxytocin

Study Locations (1)

Missouri

  • Barnes Jewish Hospital - St Louis

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2022-07-01
Est. Completion 2027-09-30
Phase NA

What the Registry Record Tells You About NCT04303702

The ClinicalTrials.gov registry entry for NCT04303702 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 237-participant average among 5 other Labor Complication trials with a reported enrollment target (69% higher). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Labor Complication appearing as the primary indexed condition, and to 2 interventions - of which Continue Oxytocin is the first listed.

NCT04303702 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT04303702 about?

NCT04303702 is a clinical study titled "The Role of Oxytocin in the Second Stage of Labor". This is a randomized controlled trial investigating the utility of oxytocin administration in the second stage of labor.

What is the current status of trial NCT04303702?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2022-07-01. Estimated completion is 2027-09-30.

What conditions does trial NCT04303702 study?

This clinical trial studies the following conditions: Labor Complication.

What interventions are being tested in trial NCT04303702?

The interventions under investigation include: Continue Oxytocin (DRUG), Discontinue Oxytocin (OTHER).

Who is sponsoring clinical trial NCT04303702?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04303702 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Labor Complication

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.